| In conclusion, miR-212 may serve as a prognostic indicator for HCC patients and exerts tumor suppressive role, at least in part, by inhibiting FOXA1. | liver, |
| study indicated that miR-212/132 functions as tumor suppressor by targeting SMAD2 in cervical cancer | cervical, |
| MicroRNA-212 functions as an epigenetic-silenced tumor suppressor involving in tumor metastasis and invasion of gastric cancer through down-regulating PXN expression | gastric, |
| MicroRNA-212 functions as a tumor-suppressor in human non-small cell lung cancer by targeting SOX4 | lung, |
| The findings suggest that miR-212 acts as a tumor suppressor in colorectal cancer by directly targeting PIK3R3. | colorectal, |
| Study first demonstrated that miR-212 is downregulated in thyroid cancer tissues and cell lines and functions as a tumor suppressor in thyroid cancer cell growth by downregulating SIRT1. | thyroid, |
| MiRNA-212 acts as a tumor-suppressor in colorectal carcinoma through targeting SOX4 | colorectal, |
| miR-132 and miR-212 cluster function as a tumor suppressor in thyroid cancer cells by CSDE1 mediated post-transcriptional program | thyroid, |
| results indicated that miR-212 was involved in tumorigenesis, and the oncogenic activity of miR-212 in non-small cell lung cancer cells was due, in part, to suppression of PTCH1 | lung, |
| MicroRNA-212 displays tumor-promoting properties in non-small cell lung cancer cells and targets the hedgehog pathway receptor PTCH1. | lung, |